Prijeđi na sadržaj

Vindesin

Izvor: Wikipedija
Datum izmjene: 7. septembra 2023. u 10:10; autor/autorica: AcaBot (razgovor | doprinosi) (uklanjam nepotreban šablon)
(razlika) ← Starija verzija | Aktualna verzija (razlika) | Novija verzija → (razlika)
Vindesin
Klinički podaci
Robne marke DAVA, Eldesine, Eldisine
AHFS/Drugs.com Monografija
Identifikatori
CAS broj 59917-39-4
ATC kod L01CA03
PubChem[1][2] 40839
DrugBank DB00309
ChemSpider[3] 37302
ChEBI CHEBI:36373 DaY
ChEMBL[4] CHEMBL219146 DaY
Hemijski podaci
Formula C43H55N5O7 
Mol. masa 753,926
SMILES eMolekuli & PubHem
Fizički podaci
Tačka topljenja 230-232 °C (-156 °F)
Farmakokinetički podaci
Poluvreme eliminacije 24 h
Farmakoinformacioni podaci
Trudnoća ?
Pravni status
Način primene Intravenozno

Vindesin je organsko jedinjenje, koje sadrži 43 atoma ugljenika i ima molekulsku masu od 753,926 Da.[5][6]

Osobine

[uredi | uredi kod]
Osobina Vrednost
Broj akceptora vodonika 10
Broj donora vodonika 5
Broj rotacionih veza 7
Particioni koeficijent[7] (ALogP) 3,7
Rastvorljivost[8] (logS, log(mol/L)) -6,1
Polarna površina[9] (PSA, Å2) 164,8

Reference

[uredi | uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  5. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682.  edit
  6. David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412.  edit
  7. Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o. 
  8. Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573.  edit
  9. Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286.  edit

Literatura

[uredi | uredi kod]

Spoljašnje veze

[uredi | uredi kod]